Pfizer readies four OTC drug brands for U.K. launch

Article Abstract:

Pfizer plans to double its sales of OTC medicines across the world to $1 billion by 2000, and as part of this strategy will probably launch OTC versions of a number of its prescription medicines in the UK during 1995. It is seeking a UK licence for an OTC version of its Feldene anti-arthritic drug, and hopes to launch the product in summer 1995 as an OTC topical analgesic. It has already received provisional approval for OTC versions of Atarax, an itching remedy, Diflucan, which treats vaginal thrush, and Combantin, which treats threadworms.

Product information, Pfizer Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Denmark launches two investigations of OTC industry

Article Abstract:

Investigations ordered by the Danish Ministry of Health are under way into the purchasing and marketing practices of the country's over-the-counter drugs industry. One enquiry has been prompted by allegations from Danish consumer groups that Danmarks Apotekerforening (DAF), the Danish retail pharmacy association, may be contravening European Union competition rules. DAF's agreement with wholesale drugs firms requires OTC suppliers to reduce prices or their products will be removed from pharmacy shelves.

Denmark, Laws, regulations and rules, Marketing

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bayer aligns $250m global account with BBDO

Article Abstract:

Bayer AG has awarded its worldwide advertising account for consumer products to advertising agency BBDO. The account, said to be worth up to $285 million a year, will include all Bayer's consumer pharmaceutical products, such as Alka-Seltzer, Bayer Aspirin and Canestan. Bayer's media buying will continue to be on a country-by-country basis.

Advertising agencies, Contracts, Advertising, Bayer AG, BBDO Worldwide Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Proprietary drugs, Nonprescription drugs
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.